← Home
Cardinal Health 
Pharma / Pharmaceutical Distribution and Services
Press Releases
| Date | Press release |
|---|---|
| 2025-05-01 06:45:00 | Cardinal Health Reports Third Quarter Fiscal Year 2025 Results And Raises Fiscal Year 2025 Outlook Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expiration gaap 1 operating earnings were $730 million; gaap diluted eps was $2.10 non-gaap operating earnings increased 21% to $807 million, driven by segment profit growth across all of the company’s operating segments; non-gaap diluted eps increased 13% to $2.35 fiscal year 2025 non-gaap eps guidance2 raised and narrowed to $8.05 to $8.15, from $7.85 to $8.00 gi alliance announces expansion into urology specialty therapeutic area dublin, ohio , may 1, 2025 /prnewswire/ -- cardinal health (nyse: cah) today reported third quarter fiscal year 2025 revenues of $54.9 billion, flat to the third quarter of fiscal year 2024. third quarter revenue increased 19% excluding the impact of the previously communicated customer contract expiration. |
| 2025-04-08 06:30:00 | Telix Announces Cardinal Health For Gozellix Commercial Distribution Melbourne, australia and indianapolis, april 08, 2025 (globe newswire) -- telix pharmaceuticals limited (asx: tlx, nasdaq: tlx, telix, the company) today announces that it has selected cardinal health, inc. (nyse: cah, cardinal health) as one of its commercial radiopharmaceutical distributors to supply finished unit doses of gozellix® (kit for the preparation of gallium-68 (68ga) gozetotide injection), telix’s next-generation psma-pet imaging1 agent for prostate cancer in the united states (u.s.). |
| 2025-03-25 06:45:00 | Cardinal Health To Announce Third-quarter Results For Fiscal Year 2025 On May 1 Dublin, ohio , march 25, 2025 /prnewswire/ -- cardinal health (nyse: cah) plans to release third-quarter financial results for its fiscal year 2025 on may 1, prior to the opening of trading on the new york stock exchange. the company will webcast a discussion of these results beginning at 8:30 a.m. |
| 2025-03-10 06:45:00 | Robert Musslewhite And Sudhakar Ramakrishna To Join Cardinal Health Board Of Directors Dublin, ohio , march 10, 2025 /prnewswire/ -- cardinal health (nyse:cah) announced today that its board of directors has elected robert musslewhite, former chief executive officer of definitive healthcare corp., and sudhakar ramakrishna, president and chief executive officer of solarwinds corporation, as independent directors, effective march 7, 2025. with more than 20 years of leadership experience, including serving as ceo for two publicly traded companies, mr. |
| 2025-02-03 17:15:00 | Cardinal Health Board Of Directors Approves Quarterly Dividend Dublin, ohio , feb. 3, 2025 /prnewswire/ -- cardinal health (nyse: cah) announced today that its board of directors approved a quarterly dividend of $0.5056 per share out of the company’s capital surplus. the dividend will be payable on april 15, 2025, to shareholders of record at the close of business on april 1, 2025. |
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Legal